Cargando…

Cholinesterase Inhibitors in Mild Cognitive Impairment: A Systematic Review of Randomised Trials

BACKGROUND: Mild cognitive impairment (MCI) refers to a transitional zone between normal ageing and dementia. Despite the uncertainty regarding the definition of MCI as a clinical entity, clinical trials have been conducted in the attempt to study the role of cholinesterase inhibitors (ChEIs) curren...

Descripción completa

Detalles Bibliográficos
Autores principales:	Raschetti, Roberto, Albanese, Emiliano, Vanacore, Nicola, Maggini, Marina
Formato:	Texto
Lenguaje:	English
Publicado:	Public Library of Science 2007
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2082649/ https://www.ncbi.nlm.nih.gov/pubmed/18044984 http://dx.doi.org/10.1371/journal.pmed.0040338

Ejemplares similares

Cholinesterase Inhibitors: Drugs Looking for a Disease?
por: Maggini, Marina, et al.
Publicado: (2006)

Prescribing cholinesterase inhibitors in mild cognitive impairment—Observations from the Alzheimer's Disease Neuroimaging Initiative
por: Stage, Eddie, et al.
Publicado: (2021)

Change in cognitive function according to cholinesterase inhibitor use and amyloid PET positivity in patients with mild cognitive impairment
por: Pyun, Jung-Min, et al.
Publicado: (2021)

Acupuncture for vascular mild cognitive impairment: a systematic review of randomised controlled trials
por: Cao, Huijuan, et al.
Publicado: (2013)

Odor identification impairment and cholinesterase inhibitor treatment in Alzheimer's disease
por: Motter, Jeffrey N., et al.
Publicado: (2021)

Saffron for mild cognitive impairment and dementia: a systematic review and meta-analysis of randomised clinical trials
por: Ayati, Zahra, et al.
Publicado: (2020)

Progress in understanding variability in cognitive responses to cholinesterase inhibitor treatment
por: Pavlik, Valory N, et al.
Publicado: (2011)

Long-term Effects of Cholinesterase Inhibitors on Cognitive Decline and Mortality
por: Xu, Hong, et al.
Publicado: (2021)

Spontaneous Reversion of Clinical Conditions Measuring the Risk Profile of the Individual: From Frailty to Mild Cognitive Impairment
por: Canevelli, Marco, et al.
Publicado: (2017)

The PACE Study: A randomised clinical trial of cognitive activity (CA) for older adults with mild cognitive impairment (MCI)
por: Vidovich, Mandy R, et al.
Publicado: (2009)

Mild Cognitive Impairment in the Migrant Population Living in Europe: An Epidemiological Estimation of the Phenomenon
por: Canevelli, Marco, et al.
Publicado: (2020)

Effectiveness of Nootropics in Combination with Cholinesterase Inhibitors on Cognitive Function in Mild-to-Moderate Dementia: A Study Using Real-World Data
por: Kang, Minjae, et al.
Publicado: (2022)

Cholinesterase inhibitors from botanicals
por: Ahmed, Faiyaz, et al.
Publicado: (2013)

Cholinesterase inhibitors as Alzheimer's therapeutics
por: Sharma, Kamlesh
Publicado: (2019)

Multifunctional Donepezil Analogues as Cholinesterase and BACE1 Inhibitors
por: Green, Keith D., et al.
Publicado: (2018)

Estimating attrition in mild-to-moderate Alzheimer’s disease and mild cognitive impairment clinical trials
por: Ritchie, Marina, et al.
Publicado: (2023)

Cognitive and Affective Changes in Mild to Moderate Alzheimer’s Disease Patients Undergoing Switch of Cholinesterase Inhibitors: A 6-Month Observational Study
por: Spalletta, Gianfranco, et al.
Publicado: (2014)

Environmental Risks of Insecticides Cholinesterase Inhibitors
por: Mandour, Raafat A.
Publicado: (2013)

Prognostic Factors in Cholinesterase Inhibitor Poisoning
por: Sun, In O, et al.
Publicado: (2015)

Proline-Based Carbamates as Cholinesterase Inhibitors †
por: Pizova, Hana, et al.
Publicado: (2017)

Honeys as Possible Sources of Cholinesterase Inhibitors
por: Szwajgier, Dominik, et al.
Publicado: (2022)

The effect of cognitive training on domains of attention in older adults with mild cognitive impairment and mild dementia: A meta-analysis of randomised controlled trials
por: Sung, Chien-Mei, et al.
Publicado: (2023)

Association of Concomitant Use of Cholinesterase Inhibitors or Memantine With Cognitive Decline in Alzheimer Clinical Trials: A Meta-analysis
por: Kennedy, Richard E., et al.
Publicado: (2018)

Profile of Cognitive Complaints in Vascular Mild Cognitive Impairment and Mild Cognitive Impairment
por: Gu, Jenny, et al.
Publicado: (2013)

Diagnosing Mild Cognitive Impairment (MCI) in clinical trials: a systematic review
por: Christa Maree Stephan, Blossom, et al.
Publicado: (2013)

Headache related to use of cholinesterase inhibitors: study of a Cognitive Function Clinic population
por: Larner, A. J.
Publicado: (2006)

Cholinesterase inhibitors, donepezil and rivastigmine, attenuate spatial memory and cognitive flexibility impairment induced by acute ethanol in the Barnes maze task in rats
por: Gawel, Kinga, et al.
Publicado: (2016)

Structure-Based Search for New Inhibitors of Cholinesterases
por: Bajda, Marek, et al.
Publicado: (2013)

Synergism of antihypertensives and cholinesterase inhibitors in Alzheimer's disease
por: Hu, Ziheng, et al.
Publicado: (2018)

Therapeutic Potential of Multifunctional Derivatives of Cholinesterase Inhibitors
por: Przybyłowska, Maja, et al.
Publicado: (2021)

A Plasma Circular RNA Profile Differentiates Subjects with Alzheimer’s Disease and Mild Cognitive Impairment from Healthy Controls
por: Piscopo, Paola, et al.
Publicado: (2022)

Mild Cognitive Impairment in Republic of Georgia
por: Janelidze, Marina, et al.
Publicado: (2018)

Effect of Baduanjin exercise on cognitive function in older adults with mild cognitive impairment: study protocol for a randomised controlled trial
por: Zheng, Guohua, et al.
Publicado: (2016)

Cognitive training and neuroplasticity in mild cognitive impairment (COG-IT): protocol for a two-site, blinded, randomised, controlled treatment trial
por: D'Antonio, Jessica, et al.
Publicado: (2019)

The effects of docosahexaenoic acid supplementation on cognition and well‐being in mild cognitive impairment: A 12‐month randomised controlled trial
por: Mengelberg, Alexia, et al.
Publicado: (2022)

Memantine and cholinesterase inhibitor combination therapy for Alzheimer's disease: a systematic review
por: Farrimond, Lucy E, et al.
Publicado: (2012)

Promoting Activity, Independence, and Stability in Early Dementia and mild cognitive impairment (PrAISED): randomised controlled trial
por: Harwood, Rowan H, et al.
Publicado: (2023)

Acetyl-cholinesterase-inhibitors slow cognitive decline and decrease overall mortality in older patients with dementia
por: Zuin, Marco, et al.
Publicado: (2022)

A case report of cholinesterase inhibitor poisoning: cholinesterase activities and analytical methods for diagnosis and clinical decision making
por: Amend, N., et al.
Publicado: (2020)

The comparative efficacy and safety of cholinesterase inhibitors in patients with mild‐to‐moderate Alzheimer's disease: a Bayesian network meta‐analysis
por: Kobayashi, Hisanori, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_sn4fu9h2f7ii4hu4k13fiect52